SOW
AUPH icon

State of Wyoming’s Aurinia Pharmaceuticals AUPH Stock Holding History

State of Wyoming’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Sell
27,469
-5,214
-16% -$76.2K 0.05% 469
2025
Q4 		$521K Sell
32,683
-5,019
-13% -$71.1K 0.06% 348
2025
Q3 		$417K Buy
37,702
+9,396
+33% +$103K 0.05% 436
2025
Q2 		$240K Buy
+28,306
New +$227K 0.03% 789
2022
Q1 		– Sell
-28
Closed -$1K – 1791
2021
Q4 		$1K Sell
28
-35
-56% -$829 ﹤0.01% 1796
2021
Q3 		$1K Buy
+63
New +$1K ﹤0.01% 1169

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State of Wyoming's AUPH Position: Q1 2026 in Review

State of Wyoming reduced its Aurinia Pharmaceuticals (AUPH) stake by 16% in Q1 2026, selling an estimated $76.2K and leaving 27,469 shares worth $407K. The position accounts for 0.05% of the portfolio, ranked #469.

State of Wyoming first reported a position in AUPH in Q3 2021 and has held it in 6 quarters since. The position peaked at $521K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • State of Wyoming held 27,469 shares of Aurinia Pharmaceuticals worth $407K as of Q1 2026.
  • State of Wyoming sold 5,214 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $76.2K.
  • Aurinia Pharmaceuticals made up 0.05% of State of Wyoming's portfolio in Q1 2026, its #469 holding.
  • State of Wyoming first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
  • State of Wyoming's Aurinia Pharmaceuticals position peaked at $521K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.